ALL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Allstate Corp (ALL) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has shown strong financial performance in the latest quarter, the recent downgrade by Goldman Sachs, concerns around market positioning, and the absence of strong trading signals suggest that waiting for clearer positive catalysts or a better entry point may be prudent.
The stock's technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 52.629, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 203.822, and resistance is at 214.74. The stock is currently trading near its pivot point of 209.281, showing no strong directional momentum.
Strong Q4 2025 financial performance with revenue up 5.08% YoY, net income up 100.26% YoY, and EPS up 103.26% YoY.
Bullish moving averages indicating potential upward momentum.
Goldman Sachs downgraded the stock to Neutral, citing concerns about market positioning, autonomous vehicle exposure, and premium growth.
Rising competition in the insurance sector, as evidenced by State Farm's premium reductions and dividend payouts.
Broader market sentiment is weak, with SP500 down 0.56%.
In Q4 2025, Allstate reported strong financial results: Revenue increased to $17.35 billion (up 5.08% YoY), net income increased to $3.8 billion (up 100.26% YoY), and EPS rose to 14.35 (up 103.26% YoY).
Analyst sentiment is mixed. Recent downgrades include Goldman Sachs lowering its rating to Neutral with a price target of $231, citing concerns about market positioning and fair valuation. However, other analysts like Keefe Bruyette and Mizuho maintain Outperform ratings with price targets of $260 and $281, respectively, reflecting optimism about Allstate's growth potential.
